Jerusalem Pharmaceuticals Co. Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was USD 36.398 million compared to USD 34.091 million a year ago. Operating income was USD 3.997 million compared to USD 5.196 million a year ago. Net income was USD 3.725 million compared to USD 5.351 million a year ago. Basic earnings per share from continuing operations was USD 0.207 compared to USD 0.297 a year ago.